Program:
The computer industry's astounding improvement in price performance is largely attributable to enhancements in microelectronics, where chips have become increasingly more dense and less expensive. Applying these concepts can bring similar benefits of speed and reduced cost to the biomedical segment, where uses such as genetic diagnostics and sequencing by hybridization have been the most aggressive applications. Numerous other uses, including miniaturization of drug screening and of instrumentation for characterization or analysis of samples, could become much more common. There are, however, a variety of new challenges that complicate the use of such technology, particularly the need to expose chips to biological or chemical solutions. These engineering, manufacturing and commercial issues, and approaches for solving them, will be covered in detail.
Registration :
Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA USA
tel: 617-630-1300
fax: 617-630-1325
Deadline for Abstracts: 8/96
Email for Requests and Registration: chi@healthtech.com